Spanish Red Biotech Pipeline

ATRYS HEALTH

mAb for diagnosis and prognosis of brain tumors and lesions

Type: Biomarkers / Diagnostic
Therapeutic area: Cancer
Central Nervous System
Indication: Glioblastoma, neurodegenerative disease
Phase: 1R+D
Studies location: Spain